Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus (PREP-COVID)

Treluyer et al., PREP-COVID, NCT04344379, PREP-COVID, NCT04344379, Jun 2020

HCQ for COVID-19

1st treatment shown to reduce risk in March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.

No treatment is 100% effective.
Protocols combine treatments.

122 participant HCQ prophylaxis RCT with results not reported over 6 years after completion.
37 HCQ RCTs have results missing long after expected1-37
The trials report a total of 20,499 patients, with 12 trials having actual enrollment of 3,639, and the remainder estimated.
Treluyer et al., 18 Jun 2020, Randomized Controlled Trial, placebo-controlled, trial NCT04344379 (history) (PREP-COVID).